The Strasbourg Institute of Human Genetics (IHU) has been granted a conditional funding of 6.5 million euros, to be distributed over three years from 2026 to 2028, according to a letter from France’s Minister of Health, Stéphanie Rist, and Minister of Research, Philippe Baptiste. This funding comes at a time when the IHU is dealing with several ongoing challenges, including financial risks and concerns about potential conflicts of interest. The letter states that the money will only be given once these conflicts are resolved. The IHU has struggled since 2022, when former director Benoît Gallix reported issues to the National Financial Prosecutor's Office (PNF), a French authority responsible for investigating financial crimes. These reports raised questions about the institute’s governance and financial practices. In addition to these concerns, there have been criticisms about the institute’s focus on the so-called "pig scanner affair," a controversy involving the use of a medical imaging device on pigs, which some argue took precedence over more urgent patient-related research. The conditional funding highlights the government’s cautious approach in supporting the IHU while ensuring that any potential conflicts of interest are fully addressed. The institute has been under scrutiny for some time, and the new funding is seen as both a lifeline and a test of its ability to meet strict conditions. The situation has also drawn attention from the public and scientific community, who are closely watching how the IHU will handle these challenges. The IHU’s situation reflects broader concerns about transparency and accountability in scientific research institutions. While the funding could help the institute continue its important work in genetics, it also underscores the need for clear governance and ethical practices. The outcome of the IHU’s efforts to resolve these issues will likely have implications for its future and for the field of human genetics in France.